2025-01-012025-12-312025-12-31false11574619SEQUENTIS HEALTH LIMITED2026-09-1673200falseiso4217:GBPxbrli:pure115746192024-12-31115746192025-12-31115746192025-01-012025-12-31115746192023-12-31115746192024-12-31115746192024-01-012024-12-3111574619bus:SmallEntities2025-01-012025-12-3111574619bus:AuditExempt-NoAccountantsReport2025-01-012025-12-3111574619bus:AbridgedAccounts2025-01-012025-12-3111574619bus:PrivateLimitedCompanyLtd2025-01-012025-12-3111574619core:WithinOneYear2025-12-3111574619core:AfterOneYear2025-12-3111574619core:WithinOneYear2024-12-3111574619core:AfterOneYear2024-12-3111574619core:ShareCapital2025-12-3111574619core:SharePremium2025-12-3111574619core:RevaluationReserve2025-12-3111574619core:OtherReservesSubtotal2025-12-3111574619core:RetainedEarningsAccumulatedLosses2025-12-3111574619core:ShareCapital2024-12-3111574619core:SharePremium2024-12-3111574619core:RevaluationReserve2024-12-3111574619core:OtherReservesSubtotal2024-12-3111574619core:RetainedEarningsAccumulatedLosses2024-12-3111574619core:LandBuildings2025-12-3111574619core:PlantMachinery2025-12-3111574619core:Vehicles2025-12-3111574619core:FurnitureFittings2025-12-3111574619core:OfficeEquipment2025-12-3111574619core:NetGoodwill2025-12-3111574619core:IntangibleAssetsOtherThanGoodwill2025-12-3111574619core:ListedExchangeTraded2025-12-3111574619core:UnlistedNon-exchangeTraded2025-12-3111574619core:LandBuildings2024-12-3111574619core:PlantMachinery2024-12-3111574619core:Vehicles2024-12-3111574619core:FurnitureFittings2024-12-3111574619core:OfficeEquipment2024-12-3111574619core:NetGoodwill2024-12-3111574619core:IntangibleAssetsOtherThanGoodwill2024-12-3111574619core:ListedExchangeTraded2024-12-3111574619core:UnlistedNon-exchangeTraded2024-12-3111574619core:LandBuildings2025-01-012025-12-3111574619core:PlantMachinery2025-01-012025-12-3111574619core:Vehicles2025-01-012025-12-3111574619core:FurnitureFittings2025-01-012025-12-3111574619core:OfficeEquipment2025-01-012025-12-3111574619core:NetGoodwill2025-01-012025-12-3111574619core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3111574619core:ListedExchangeTraded2025-01-012025-12-3111574619core:UnlistedNon-exchangeTraded2025-01-012025-12-3111574619core:MoreThanFiveYears2025-01-012025-12-3111574619core:Non-currentFinancialInstruments2025-12-3111574619core:Non-currentFinancialInstruments2024-12-3111574619dpl:CostSales2025-01-012025-12-3111574619dpl:DistributionCosts2025-01-012025-12-3111574619core:LandBuildings2025-01-012025-12-3111574619core:PlantMachinery2025-01-012025-12-3111574619core:Vehicles2025-01-012025-12-3111574619core:FurnitureFittings2025-01-012025-12-3111574619core:OfficeEquipment2025-01-012025-12-3111574619dpl:AdministrativeExpenses2025-01-012025-12-3111574619core:NetGoodwill2025-01-012025-12-3111574619core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3111574619dpl:GroupUndertakings2025-01-012025-12-3111574619dpl:ParticipatingInterests2025-01-012025-12-3111574619dpl:GroupUndertakingscore:ListedExchangeTraded2025-01-012025-12-3111574619core:ListedExchangeTraded2025-01-012025-12-3111574619dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-01-012025-12-3111574619core:UnlistedNon-exchangeTraded2025-01-012025-12-3111574619dpl:CostSales2024-01-012024-12-3111574619dpl:DistributionCosts2024-01-012024-12-3111574619core:LandBuildings2024-01-012024-12-3111574619core:PlantMachinery2024-01-012024-12-3111574619core:Vehicles2024-01-012024-12-3111574619core:FurnitureFittings2024-01-012024-12-3111574619core:OfficeEquipment2024-01-012024-12-3111574619dpl:AdministrativeExpenses2024-01-012024-12-3111574619core:NetGoodwill2024-01-012024-12-3111574619core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3111574619dpl:GroupUndertakings2024-01-012024-12-3111574619dpl:ParticipatingInterests2024-01-012024-12-3111574619dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3111574619core:ListedExchangeTraded2024-01-012024-12-3111574619dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3111574619core:UnlistedNon-exchangeTraded2024-01-012024-12-3111574619core:NetGoodwill2025-12-3111574619core:IntangibleAssetsOtherThanGoodwill2025-12-3111574619core:LandBuildings2025-12-3111574619core:PlantMachinery2025-12-3111574619core:Vehicles2025-12-3111574619core:FurnitureFittings2025-12-3111574619core:OfficeEquipment2025-12-3111574619core:AfterOneYear2025-12-3111574619core:WithinOneYear2025-12-3111574619core:ListedExchangeTraded2025-12-3111574619core:UnlistedNon-exchangeTraded2025-12-3111574619core:ShareCapital2025-12-3111574619core:SharePremium2025-12-3111574619core:RevaluationReserve2025-12-3111574619core:OtherReservesSubtotal2025-12-3111574619core:RetainedEarningsAccumulatedLosses2025-12-3111574619core:NetGoodwill2024-12-3111574619core:IntangibleAssetsOtherThanGoodwill2024-12-3111574619core:LandBuildings2024-12-3111574619core:PlantMachinery2024-12-3111574619core:Vehicles2024-12-3111574619core:FurnitureFittings2024-12-3111574619core:OfficeEquipment2024-12-3111574619core:AfterOneYear2024-12-3111574619core:WithinOneYear2024-12-3111574619core:ListedExchangeTraded2024-12-3111574619core:UnlistedNon-exchangeTraded2024-12-3111574619core:ShareCapital2024-12-3111574619core:SharePremium2024-12-3111574619core:RevaluationReserve2024-12-3111574619core:OtherReservesSubtotal2024-12-3111574619core:RetainedEarningsAccumulatedLosses2024-12-3111574619core:NetGoodwill2023-12-3111574619core:IntangibleAssetsOtherThanGoodwill2023-12-3111574619core:LandBuildings2023-12-3111574619core:PlantMachinery2023-12-3111574619core:Vehicles2023-12-3111574619core:FurnitureFittings2023-12-3111574619core:OfficeEquipment2023-12-3111574619core:AfterOneYear2023-12-3111574619core:WithinOneYear2023-12-3111574619core:ListedExchangeTraded2023-12-3111574619core:UnlistedNon-exchangeTraded2023-12-3111574619core:ShareCapital2023-12-3111574619core:SharePremium2023-12-3111574619core:RevaluationReserve2023-12-3111574619core:OtherReservesSubtotal2023-12-3111574619core:RetainedEarningsAccumulatedLosses2023-12-3111574619core:AfterOneYear2025-01-012025-12-3111574619core:WithinOneYear2025-01-012025-12-3111574619core:Non-currentFinancialInstrumentscore:CostValuation2025-01-012025-12-3111574619core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-012025-12-3111574619core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-012025-12-3111574619core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-012025-12-3111574619core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-012025-12-3111574619core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-012025-12-3111574619core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3111574619core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3111574619core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3111574619core:Non-currentFinancialInstrumentscore:CostValuation2025-12-3111574619core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-12-3111574619core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-12-3111574619core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-12-3111574619core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-12-3111574619core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-12-3111574619core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-12-3111574619core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-12-3111574619core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-12-3111574619core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3111574619core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3111574619core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3111574619core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3111574619core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3111574619core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3111574619core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3111574619core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3111574619core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3111574619bus:Director12025-01-012025-12-3111574619bus:Director22025-01-012025-12-3111574619bus:Director32025-01-012025-12-31

SEQUENTIS HEALTH LIMITED

Registered Number
11574619
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2025

SEQUENTIS HEALTH LIMITED
Company Information
for the year from 1 January 2025 to 31 December 2025

Directors

GRAINGER, Darren
LE GUISQUET, Godefroy
LOEWENTHAL, Matthew, Dr

Company Secretary

COOPER FAURE LIMITED

Registered Address

4 Vicarage Road
Teddington
TW11 8EZ

Registered Number

11574619 (England and Wales)
SEQUENTIS HEALTH LIMITED
Balance Sheet as at
31 December 2025

Notes

2025

2024

£

£

£

£

Called up share capital not paid11
Fixed assets
Tangible assets326,56420,521
26,56420,521
Current assets
Debtors2,012,0721,078,775
Cash at bank and on hand357,318490,519
2,369,3901,569,294
Creditors amounts falling due within one year(2,314,705)(1,256,631)
Net current assets (liabilities)54,686312,664
Total assets less current liabilities81,250333,185
Creditors amounts falling due after one year(46,000)(95,000)
Net assets35,250238,185
Capital and reserves
Called up share capital11
Profit and loss account35,249238,184
Shareholders' funds35,250238,185
The financial statements were approved and authorised for issue by the Board of Directors on 16 September 2026, and are signed on its behalf by:
LE GUISQUET, Godefroy
Director
Registered Company No. 11574619
SEQUENTIS HEALTH LIMITED
Notes to the Financial Statements
for the year ended 31 December 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
2.Average number of employees

20252024
Average number of employees during the year2923
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 January 2544,634
Additions15,792
At 31 December 2560,426
Depreciation and impairment
At 01 January 2524,112
Charge for year9,750
At 31 December 2533,861
Net book value
At 31 December 2526,564
At 31 December 2420,521